18Fluorodeoxyglucose Positron Emission Tomography Imaging of Atherosclerotic Plaque Inflammation Is Highly Reproducible. Implications for Atherosclerosis Therapy Trials

Journal of the American College of Cardiology

Volumn 50, Issue 9, 2007, Pages 892-896

  Rudd, James H F ^a   Myers, Kelly S ^a   Bansilal, Sameer ^a   Machac, Josef ^a   Rafique, Ash ^a   Farkouh, Michael ^a   Fuster, Valentin ^a   Fayad, Zahi A ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; AORTA; ARTICLE; ATHEROMA; ATHEROSCLEROTIC PLAQUE; CAROTID ARTERY; CLINICAL ARTICLE; DISEASE MARKER; FEMALE; HUMAN; INFLAMMATION; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REPRODUCIBILITY; VALIDATION PROCESS; VERTEBRAL ARTERY;

AGED; AORTIC DISEASES; ATHEROSCLEROSIS; CAROTID ARTERY DISEASES; DIABETIC ANGIOPATHIES; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; INFLAMMATION; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY;

EID: 34547954508     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.05.024     Document Type: Article

References (14)

1. Choudhury R.P., Fuster V., and Fayad Z.A. Molecular, cellular and functional imaging of atherothrombosis. Nat Rev Drug Discov 3 (2004) 913-925
2. Avril N.E., and Weber W.A. Monitoring response to treatment in patients utilizing PET. Radiol Clin North Am 43 (2005) 189-204
3. Rudd J.H.F., Warburton E.A., Fryer T.D., et al. Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 105 (2002) 2708-2711
4. Davies J.R., Rudd J.H., Fryer T.D., et al. Identification of culprit lesions after transient ischemic attack by combined 18F fluorodeoxyglucose positron-emission tomography and high-resolution magnetic resonance imaging. Stroke 36 (2005) 2642-2647
5. Dunphy M.P., Freiman A., Larson S.M., and Strauss H.W. Association of vascular 18F-FDG uptake with vascular calcification. J Nucl Med 46 (2005) 1278-1284
6. Tawakol A., Migrino R.Q., Bashian G.G., et al. In vivo 18F-fluorodeoxyglucose positron emission tomography imaging provides a noninvasive measure of carotid plaque inflammation in patients. J Am Coll Cardiol 48 (2006) 1818-1824
7. Ogawa M., Magata Y., Kato T., et al. Application of 18F-FDG-PET for monitoring the therapeutic effect of antiinflammatory drugs on stabilization of vulnerable atherosclerotic plaques. J Nucl Med 47 (2006) 1845-1850
8. Tahara N., Kai H., Ishibashi M., et al. Simvastatin attenuates plaque inflammation: evaluation by fluorodeoxyglucose positron emission tomography. J Am Coll Cardiol 48 (2006) 1825-1831
9. Weber W.A., Ziegler S.I., Thodtmann R., Hanauske A.R., and Schwaiger M. Reproducibility of metabolic measurements in malignant tumors using FDG-PET. J Nucl Med 40 (1999) 1771-1777
10. Eliasziw M., Young S.L., Woodbury M.G., and Fryday-Field K. Statistical methodology for the concurrent assessment of interrater and intrarater reliability: using goniometric measurements as an example. Phys Ther 74 (1994) 777-788
11. Varghese A., Crowe L.A., Mohiaddin R.H., et al. Inter-study reproducibility of 3D volume selective fast spin echo sequence for quantifying carotid artery wall volume in asymptomatic subjects. Atherosclerosis 183 (2005) 361-366
12. Hagenaars T., Gussenhoven E.J., van Essen J.A., Seelen J., Honkoop J., and van der Lugt A. Reproducibility of volumetric quantification in intravascular ultrasound images. Ultrasound Med Biol 26 (2000) 367-374
13. Budoff M.J., Achenbach S., Blumenthal R.S., et al. Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation 114 (2006) 1761-1791
14. Corti R., Fuster V., Fayad Z.A., et al. Effects of aggressive versus conventional lipid-lowering therapy by simvastatin on human atherosclerotic lesions: a prospective, randomized, double-blind trial with high-resolution magnetic resonance imaging. J Am Coll Cardiol 46 (2005) 106-112